PFIZER, INC. |
Market Closed -
Other stock markets
|
After market 07:04:03 pm | |||
| 29.66 USD | -0.30% |
|
29.74 | +0.29% |
| Sep. 18 | GSK settles two California lawsuits related to heartburn drug Zantac | RE |
| Sep. 18 | Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports | RE |
EPS & Dividend: Pfizer, Inc.
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 1.44 | 1.52 | 1.56 | 1.61 | 1.65 | 1.665 | 1.697 | 1.715 |
| Rate of return | 3.68% | 4.13% | 2.64% | 3.14% | 5.73% | 5.61% | 5.72% | 5.78% |
| EPS 2 | 2.87 | 1.71 | 3.85 | 5.47 | 0.37 | 1.362 | 2.001 | 2.203 |
| Distribution rate | 50.2% | 88.9% | 40.5% | 29.4% | 446% | 122% | 84.8% | 77.8% |
| Reference price 2 | 39.18 | 36.81 | 59.05 | 51.24 | 28.79 | 29.66 | 29.66 | 29.66 |
| Nbr of stocks (in thousands) | 5,534,122 | 5,558,397 | 5,612,867 | 5,613,315 | 5,646,413 | 5,666,695 | - | - |
| Announcement Date | 1/28/20 | 2/2/21 | 2/8/22 | 1/31/23 | 1/30/24 | - | - | - |
1USD in Million2USD
Estimates
Past dividends: Pfizer, Inc.
| 2024-07-25 | Quarterly 0.42 USD |
| 2024-05-08 | Quarterly 0.42 USD |
| 2024-01-24 | Quarterly 0.42 USD |
| 2023-11-08 | Quarterly 0.41 USD |
| 2023-07-26 | Quarterly 0.41 USD |
| 2023-05-10 | Quarterly 0.41 USD |
| 2023-01-25 | Quarterly 0.41 USD |
| 2022-11-02 | Quarterly 0.4 USD |
| 2022-07-27 | Quarterly 0.4 USD |
| 2022-05-11 | Quarterly 0.4 USD |
| 2022-01-26 | Quarterly 0.4 USD |
| 2021-11-03 | Quarterly 0.39 USD |
| 2021-07-28 | Quarterly 0.39 USD |
| 2021-05-05 | Quarterly 0.39 USD |
| 2021-01-27 | Quarterly 0.39 USD |
| 2020-11-04 | Quarterly 0.38 USD |
| 2020-07-29 | Quarterly 0.38 USD |
| 2020-05-06 | Quarterly 0.38 USD |
| 2020-01-29 | Quarterly 0.38 USD |
Upcoming events: Pfizer, Inc.
More events
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| +5.61% | +5.72% | 21.78x | 1.917 | 3.72x | ||
| +0.57% | +0.66% | 59x | 40.65 | 18.28x | ||
| +1.27% | +1.67% | 39.55x | 27.72 | 13.77x | ||
| +2.84% | +3.12% | 21.1x | 5.616 | 4.56x | ||
| +3.22% | +3.33% | 37.68x | 40.93 | 7.14x | ||
| +2.62% | +2.76% | 15.63x | 6.055 | 4.97x | ||
| +3.68% | +3.78% | 16.05x | 5.860 | 3.79x | ||
| +1.96% | +2.07% | 28.29x | 5.819 | 5.09x | ||
| +3.26% | +3.38% | 21.55x | 5.270 | 4.96x | ||
| +2.73% | +2.95% | 51.75x | 35.98 | 6.95x | ||
| Average | +2.78% | +2.94% | 31.24x | 17.58 | 7.32x | |
| Weighted average by Cap. | +2.22% | +2.40% | 35.94x | 22.33 | 9.68x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
